Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 14/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 12/20 | 0.54 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.48 |
| ▸ | RELA | Q04206 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7040490 | 0.89 | USP2 (0.55) | HTR2CUSP2HTR2AHTR2BCYP11B2 | |
| SCHEMBL9035888 | 0.75 | HTR2C (1.00) | HTR2CHTR2ANPC1NFKB1RAB9A | |
| SCHEMBL7079712 | 0.71 | HTR2C (0.77) | HTR2CHTR2AHTR2BNPC1RAB9A | |
| SCHEMBL5923917 | 0.70 | MAPT (0.67) | USP2MAPTNPC1NFKB1RAB9A | |
| SCHEMBL8526803 | 0.69 | HTR2C (1.00) | HTR2CHTR2ACYP11B2 | |
| SCHEMBL25112365 | 0.69 | USP2 (0.57) | HTR2CUSP2HTR2BMAPTNPC1 | |
| SCHEMBL8526818 | 0.68 | HTR2C (1.00) | HTR2CHTR2AHTR2B | |
| SCHEMBL8527508 | 0.68 | HTR2C (1.00) | HTR2CHTR2AHTR2B | |
| SCHEMBL8526790 | 0.68 | HTR2C (1.00) | HTR2CHTR2AHTR2B | |
| SCHEMBL8526238 | 0.68 | HTR2C (1.00) | HTR2CHTR2AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003011281-A1 | TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER OR ATTENTION DEFICIT DISORDER | VERNALIS RESEARCH LIMITED (GB) | 2003-02-13 | — | — | WO | disclosed |
| EP-0808312-A1 | INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST | SMITHKLINE BEECHAM PLC (GB) | 1997-11-26 | — | — | EP | disclosed |